Luye Pharma -Approval Obtained for Initiating Clinical Trials for- Innovative Dual Taar1/5-Ht2Cr Agonist
綠葉製藥-獲批開始開展革新的雙重Taar1/5-Ht2Cr激動劑的臨床試驗。
Luye Pharma -Approval Obtained for Initiating Clinical Trials for- Innovative Dual Taar1/5-Ht2Cr Agonist
綠葉製藥-獲批開始開展革新的雙重Taar1/5-Ht2Cr激動劑的臨床試驗。
使用瀏覽器的分享功能,分享給你的好友吧